TR201909387T4 - Glikojen bazlı katyonik polimerler. - Google Patents

Glikojen bazlı katyonik polimerler. Download PDF

Info

Publication number
TR201909387T4
TR201909387T4 TR2019/09387T TR201909387T TR201909387T4 TR 201909387 T4 TR201909387 T4 TR 201909387T4 TR 2019/09387 T TR2019/09387 T TR 2019/09387T TR 201909387 T TR201909387 T TR 201909387T TR 201909387 T4 TR201909387 T4 TR 201909387T4
Authority
TR
Turkey
Prior art keywords
alkyl
alkylamino
group
glycogen
different
Prior art date
Application number
TR2019/09387T
Other languages
English (en)
Turkish (tr)
Inventor
Russo Vincenzo
Liberati Elisa
Cazzolla Nicola
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of TR201909387T4 publication Critical patent/TR201909387T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/18Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
TR2019/09387T 2012-03-15 2013-02-21 Glikojen bazlı katyonik polimerler. TR201909387T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12159710 2012-03-15

Publications (1)

Publication Number Publication Date
TR201909387T4 true TR201909387T4 (tr) 2019-07-22

Family

ID=47739282

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09387T TR201909387T4 (tr) 2012-03-15 2013-02-21 Glikojen bazlı katyonik polimerler.

Country Status (29)

Country Link
US (1) US9717801B2 (https=)
EP (1) EP2825565B1 (https=)
JP (1) JP6247234B2 (https=)
KR (1) KR101997018B1 (https=)
CN (2) CN104080812B (https=)
AR (1) AR090307A1 (https=)
AU (1) AU2013231561B2 (https=)
BR (1) BR112014018617A8 (https=)
CA (1) CA2859273C (https=)
CY (1) CY1121829T1 (https=)
DK (1) DK2825565T3 (https=)
EA (1) EA032479B1 (https=)
ES (1) ES2732216T3 (https=)
GE (1) GEP201606581B (https=)
HR (1) HRP20191114T1 (https=)
HU (1) HUE045049T2 (https=)
IL (1) IL233823B (https=)
LT (1) LT2825565T (https=)
ME (1) ME03429B (https=)
MX (1) MX351599B (https=)
PL (1) PL2825565T3 (https=)
PT (1) PT2825565T (https=)
RS (1) RS58985B1 (https=)
SG (2) SG11201403816YA (https=)
SI (1) SI2825565T1 (https=)
SM (1) SMT201900342T1 (https=)
TR (1) TR201909387T4 (https=)
UA (1) UA115135C2 (https=)
WO (1) WO2013135471A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095937A1 (es) 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno
BR112015027134A8 (pt) 2013-04-26 2019-12-24 Mirexus Biotechnologies Inc método e aditivo para mudar o comportamento reológico de uma formulação à base de água ou à base de álcool, composição e método para estabilizar uma formulação ou aumentar a fotoestabilidade de compostos orgânicos
BR112017014090A2 (pt) * 2014-12-29 2018-03-06 Bonac Corporation composição, e, métodos para produção de uma composição e estabilização de uma molécula de ácido nucleico.
CN104558246B (zh) * 2015-01-20 2017-03-01 武汉理工大学 一种叶酸/生物素修饰的壳聚糖材料及其制备方法
DE102015205088C5 (de) * 2015-03-20 2024-09-26 Kuka Deutschland Gmbh Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu
JP6872782B2 (ja) * 2016-03-08 2021-05-19 国立大学法人京都大学 カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤
CN109310644A (zh) * 2016-04-14 2019-02-05 奇迹连结生物技术公司 包含植物糖原纳米颗粒的抗感染组合物
BR112018072452A2 (pt) * 2016-05-04 2019-02-19 Mirexus Biotechnologies Inc. nanopartículas de glicogênio e fitoglicogênio como compostos imunossupressores, e composições e métodos para uso dos mesmos
CN105949344B (zh) * 2016-05-13 2019-05-17 中山大学 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用
WO2019027999A1 (en) * 2017-07-31 2019-02-07 Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND USES THEREOF
US11384161B2 (en) 2018-01-11 2022-07-12 Virginia Tech Intellectual Properties, Inc. Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture
CN116178587B (zh) * 2023-02-28 2025-04-11 江南大学 一种季铵盐化糖原、复合抗菌水凝胶及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904370D0 (en) 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US7144713B1 (en) 1995-10-02 2006-12-05 Emd Biosciences, Inc. Method for precipitating nucleic acid with visible carrier
GB9600272D0 (en) 1996-01-06 1996-03-06 Univ Nottingham Polymers
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
EP1399189A1 (en) 2001-06-11 2004-03-24 Universite De Montreal Compositions and methods for enhancing nucleic acid transfer into cells
US20030147958A1 (en) 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
US20030186916A1 (en) 2002-03-12 2003-10-02 Lei Yu Vector for transfection of eukaryotic cells
JPWO2005094894A1 (ja) 2004-03-31 2008-02-14 株式会社メドジェル 細胞に核酸を導入するための製剤
WO2007038769A1 (en) 2005-09-28 2007-04-05 Hetzel Adrian H Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device
UA97559C2 (uk) 2007-11-08 2012-02-27 Оцука Фармасьютікал Ко., Лтд. Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти
CN101235098A (zh) * 2008-01-09 2008-08-06 浙江大学 功能性植物多糖的修饰方法
ES2393529T3 (es) * 2008-12-22 2012-12-26 Unilever Nv Composiciones de lavandería
ES2398430T3 (es) * 2008-12-22 2013-03-19 Unilever Nv Composiciones para el lavado de ropa
EP2428578B1 (en) * 2009-05-08 2016-03-23 Ezaki Glico Co., Ltd. Glucuronic acid-containing glucan, process for production of same, and use of same
EP2275085A1 (en) * 2009-07-07 2011-01-19 University of Rostock Biodegradable copolymer suitable for delivering nucleic acid materials into cells
CN102068698A (zh) * 2009-11-24 2011-05-25 深圳先进技术研究院 纳米疫苗及其制备方法

Also Published As

Publication number Publication date
ES2732216T3 (es) 2019-11-21
KR20150006414A (ko) 2015-01-16
WO2013135471A1 (en) 2013-09-19
KR101997018B1 (ko) 2019-07-05
CN104080812B (zh) 2017-06-27
ME03429B (me) 2020-01-20
LT2825565T (lt) 2019-07-10
SI2825565T1 (sl) 2019-08-30
SG10201607577QA (en) 2016-11-29
PT2825565T (pt) 2019-07-10
SG11201403816YA (en) 2014-08-28
BR112014018617A8 (pt) 2017-07-11
AU2013231561A1 (en) 2014-07-10
CN107236052A (zh) 2017-10-10
CY1121829T1 (el) 2020-07-31
UA115135C2 (uk) 2017-09-25
CA2859273A1 (en) 2013-09-19
MX351599B (es) 2017-10-20
BR112014018617A2 (https=) 2017-06-20
EA032479B1 (ru) 2019-06-28
CN104080812A (zh) 2014-10-01
AU2013231561B2 (en) 2017-06-08
EP2825565A1 (en) 2015-01-21
IL233823A0 (en) 2014-09-30
JP6247234B2 (ja) 2017-12-13
AR090307A1 (es) 2014-11-05
JP2015510020A (ja) 2015-04-02
HUE045049T2 (hu) 2019-12-30
RS58985B1 (sr) 2019-08-30
EP2825565B1 (en) 2019-04-03
GEP201606581B (en) 2016-11-25
DK2825565T3 (da) 2019-06-24
HK1203984A1 (en) 2015-11-06
CN107236052B (zh) 2019-09-24
PL2825565T3 (pl) 2019-10-31
US9717801B2 (en) 2017-08-01
MX2014010698A (es) 2015-03-10
US20140378532A1 (en) 2014-12-25
CA2859273C (en) 2020-04-14
EA201491613A1 (ru) 2014-12-30
HRP20191114T1 (hr) 2019-09-20
IL233823B (en) 2018-05-31
SMT201900342T1 (it) 2019-07-11

Similar Documents

Publication Publication Date Title
TR201909387T4 (tr) Glikojen bazlı katyonik polimerler.
Jin et al. Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery
Khan et al. Polysaccharide gene transfection agents
Muddineti et al. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells
Jain et al. A new horizon in modifications of chitosan: syntheses and applications
Kuroki et al. Broad‐Spectrum antiviral peptides and polymers
EP2903651B1 (en) Carboxylated polyamine derivatives as transfection reagents
CN103059291B (zh) 聚(γ-寡聚乙二醇单甲醚-L-谷氨酸酯)-聚氨基酸两嵌段共聚物及其制备方法
Licciardi et al. Synthesis and characterization of polyaminoacidic polycations for gene delivery
Yi et al. Fabrication, characterization, and in vitro evaluation of doxorubicin-coupled chitosan oligosaccharide nanoparticles
Arpa et al. Chitosan-based nanogels in modern drug delivery: Focus on protein and gene applications
Wang et al. Synthesis and evaluation of chitosan-graft-polyethylenimine as a gene vector
Phunpee et al. Brush-structured chitosan/PolyHEMA with thymine and its synergistic effect on the specific interaction with ssDNA and cellular uptake
PL224855B1 (pl) Zastosowanie modyfikowanych polisacharydów do neutralizacji heparyny
Szymańska et al. From the lab to the market: Current use, perspectives, and challenges of chitosan-based materials
HK1203984B (en) Glycogen-based cationic polymers
Ryu et al. Synthesis and characterization of guanidinylated polyethylenimine-conjugated chitosan for gene delivery systems
CN102181464B (zh) 一种改性葡聚糖转基因载体及其制备方法与应用
Soradech Linear polyethyleneimine and derivatives as potential biomaterials and excipients for drug delivery
TR202011542A2 (tr) Modi̇fi̇ye edi̇lmi̇ş ki̇tosan esasli nanoparti̇küler gen taşiyici si̇stem
Park et al. Highly Osmotic Oxidized Sucrose-Crosslinked Polyethylenimine for Gene Delivery Systems. Pharmaceutics 2021, 13, 87
EP2995627B1 (en) Synthesis of nanoparticular gene carrier systems based on chitosan
Biswas Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells
Mantovani A New Horizon in Modifications of Chitosan: Syntheses and Applications